Esperion Therapeutics, Inc. (ESPR) SEC filings
ESPR SEC filings moved a median of 0.00% by the close. ESPR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ESPR overview →
74 measured ESPR SEC filing events.
Where these ESPR SEC filings landedvs 66 measured ESPR SEC filing reactions
| Middle 50% of ESPR SEC filing reactions | -3.32% to +2.80% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 66 |
Point-in-time · zero look-ahead
Half of the 66 ESPR SEC filing events with a measured close landed between -3.32% and +2.80%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Esperion Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Esperion Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 8-K Esperion Therapeutics, For: Jul 13 | SEC filing · Form 8-K | — | — | |
| Form POS AM Esperion Therapeutics, | SEC filing · Form POS | — | — | |
| Form POS462B Esperion Therapeutics, | SEC filing · Form POS462B | — | — | |
| Form POSASR Esperion Therapeutics, | SEC filing · Form POSASR | — | — | |
| Form S-8 POS Esperion Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K Esperion Therapeutics, For: Jul 08 | SEC filing · Form 8-K | +0.32% | +0.95% | |
| Form 8-K/A Esperion Therapeutics, For: Apr 02 | SEC filing · Form 8-K | +0.00% | +0.32% | |
| Form 8-K Esperion Therapeutics, For: Jun 15 | SEC filing · Form 8-K | +0.00% | +0.64% | |
| Form DEFA14A Esperion Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +0.64% | |
| Form 8-K Esperion Therapeutics, For: Jun 02 | SEC filing · Form 8-K | +0.16% | +0.00% | |
| Form DEFM14A Esperion Therapeutics, | SEC filing · Form DEFM14A | +0.00% | +0.00% | |
| Form 8-K Esperion Therapeutics, For: May 28 | SEC filing · Form 8-K | +0.00% | +0.32% | |
| Form PREM14A Esperion Therapeutics, For: May 29 | SEC filing · Form PREM14A | +0.16% | +0.00% | |
| Form 10-Q Esperion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.16% | -0.32% | |
| Form DEFA14A Esperion Therapeutics, | SEC filing · Form DEFA14A | +0.16% | +0.32% | |
| Form 8-K Esperion Therapeutics, For: May 01 | SEC filing · Form 8-K | +0.00% | -0.16% | |
| Form DEFA14A Esperion Therapeutics, | SEC filing · Form DEFA14A | -0.03% | -0.03% | |
| Form ARS Esperion Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.71% | -3.32% | |
| Form DEF 14A Esperion Therapeutics, For: Apr 16 | SEC filing · Form DEF | +0.71% | -3.32% | |
| Form DEFA14A Esperion Therapeutics, | SEC filing · Form DEFA14A | +0.71% | -3.32% | |
| Form 8-K Esperion Therapeutics, For: Apr 02 | SEC filing · Form 8-K | +3.81% | -2.67% | |
| Form 10-K Esperion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.12% | -3.36% | |
| Form 8-K Esperion Therapeutics, For: Mar 10 | SEC filing · Form 8-K | +2.24% | -13.46% | |
| Form 8-K Esperion Therapeutics, For: Mar 02 | SEC filing · Form 8-K | -1.26% | -8.20% | |
| Form 8-K Esperion Therapeutics, For: Jan 11 | SEC filing · Form 8-K | -2.33% | -8.27% | |
| Form 10-Q Esperion Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.40% | +6.40% | |
| Form 8-K Esperion Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -5.80% | -9.42% | |
| Form 8-K Esperion Therapeutics, For: Nov 04 | SEC filing · Form 8-K | +2.28% | +0.00% | |
| Form 8-K Esperion Therapeutics, For: Oct 07 | SEC filing · Form 8-K | -0.58% | -5.58% | |
| Form 8-K Esperion Therapeutics, For: Oct 07 | SEC filing · Form 8-K | -6.13% | +1.58% | |
| Form 10-Q Esperion Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.03% | +6.70% | |
| Form S-8 Esperion Therapeutics, | SEC filing · Form S-8 | -1.03% | +6.70% | |
| Form 8-K/A Esperion Therapeutics, For: Aug 05 | SEC filing · Form 8-K | -2.14% | -1.34% | |
| Form NT 10-Q Esperion Therapeutics, For: Jun 30 | SEC filing · Form NT | -1.07% | — | |
| Form 8-K Esperion Therapeutics, For: Aug 05 | SEC filing · Form 8-K | -0.31% | -0.61% | |
| Form 8-K Esperion Therapeutics, For: Jul 01 | SEC filing · Form 8-K | +1.87% | +3.95% | |
| Form 8-K Esperion Therapeutics, For: May 29 | SEC filing · Form 8-K | +2.37% | +12.19% | |
| Form 10-Q Esperion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.46% | |
| Form 8-K Esperion Therapeutics, For: May 06 | SEC filing · Form 8-K | +3.96% | -3.42% | |
| Form EFFECT Esperion Therapeutics, | SEC filing · Form EFFECT | +2.10% | +5.20% | |
| Form S-3 Esperion Therapeutics, | SEC filing · Form S-3 | -1.52% | -8.39% | |
| Form ARS Esperion Therapeutics, For: Dec 31 | SEC filing · Form ARS | -1.52% | -8.39% | |
| Form DEF 14A Esperion Therapeutics, For: Apr 17 | SEC filing · Form DEF | -1.52% | -8.39% | |
| Form DEFA14A Esperion Therapeutics, | SEC filing · Form DEFA14A | -1.52% | -8.39% | |
| Form 8-K Esperion Therapeutics, For: Apr 04 | SEC filing · Form 8-K | -2.10% | +0.84% | |
| Form 8-K Esperion Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -0.72% | +0.72% | |
| Form 10-K Esperion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.64% | +7.64% | |
| Form 8-K Esperion Therapeutics, For: Mar 04 | SEC filing · Form 8-K | -0.91% | +7.27% | |
| Form 8-K Esperion Therapeutics, For: Jan 15 | SEC filing · Form 8-K | -0.69% | +4.63% | |
| Form 8-K Esperion Therapeutics, For: Dec 17 | SEC filing · Form 8-K | -2.76% | -10.00% | |
| Form 8-K Esperion Therapeutics, For: Dec 12 | SEC filing · Form 8-K | -2.06% | +3.21% | |
| Form 10-Q Esperion Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.20% | +9.09% | |
| Form 8-K Esperion Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +4.48% | +4.97% | |
| Form 10-Q Esperion Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.88% | -3.23% | |
| Form 8-K Esperion Therapeutics, For: Aug 12 | SEC filing · Form 8-K | +2.15% | -1.07% | |
| Form S-8 Esperion Therapeutics, | SEC filing · Form S-8 | -1.88% | -3.23% | |
| Form 8-K Esperion Therapeutics, For: Aug 03 | SEC filing · Form 8-K | -1.21% | -2.43% | |
| Form 8-K Esperion Therapeutics, For: Jun 27 | SEC filing · Form 8-K | +2.36% | -10.48% | |
| Form 8-K Esperion Therapeutics, For: May 23 | SEC filing · Form 8-K | +0.24% | +4.33% | |
| Form 8-K Esperion Therapeutics, For: May 08 | SEC filing · Form 8-K | +2.42% | +0.97% | |
| Form 10-Q Esperion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +5.27% | +0.00% | |
| Form 8-K Esperion Therapeutics, For: May 07 | SEC filing · Form 8-K | +5.27% | +0.00% | |
| Form ARS Esperion Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.29% | -8.15% | |
| Form DEF 14A Esperion Therapeutics, For: Apr 11 | SEC filing · Form DEF | +1.29% | -8.15% | |
| Form 10-K Esperion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.53% | +9.43% | |
| Form 8-K Esperion Therapeutics, For: Feb 27 | SEC filing · Form 8-K | -4.53% | +9.43% | |
| Form 8-K Esperion Therapeutics, For: Jan 18 | SEC filing · Form 8-K | -2.66% | +3.87% | |
| Form 8-K Esperion Therapeutics, For: Jan 18 | SEC filing · Form 8-K | +7.15% | +20.24% | |
| Form 8-K Esperion Therapeutics, For: Jan 10 | SEC filing · Form 8-K | -0.32% | -2.58% | |
| Form 8-K Esperion Therapeutics, For: Jan 02 | SEC filing · Form 8-K | -5.12% | -5.74% | |
| Form 10-Q Esperion Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.83% | |
| Form 8-K Esperion Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +0.00% | -2.83% |
Keep exploring
More ESPR: earnings → · analyst actions → · ESPR overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Blueprint Medicines Corporation (BPMC) | 401 | -0.03% | 46% |
| EDGE THERAPEUTICS (EDGE) | 401 | -0.05% | 41% |
| Novavax, Inc. (NVAX) | 400 | 0.00% | 48% |
| AMEDICA CORP COMMON STOCK (AMDA) | 397 | -1.09% | 31% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.